Literature DB >> 23186212

Assembly of the Marburg virus envelope.

Eva Mittler1, Larissa Kolesnikova, Astrid Herwig, Olga Dolnik, Stephan Becker.   

Abstract

The key player to assemble the filamentous Marburg virus particles is the matrix protein VP40 which orchestrates recruitment of nucleocapsid complexes and the viral glycoprotein GP to the budding sites at the plasma membrane. Here, VP40 induces the formation of the viral particles, determines their morphology and excludes cellular proteins from the virions. Budding takes place at filopodia in non-polarized cells and at the basolateral cell pole in polarized epithelial cells. Molecular basis of how VP40 exerts its multifunctional role in these different processes is currently under investigation. Here we summarize recent data on structure-function relationships of VP40 and GP in connection with their function in assembly. Questions concerning the complex particle assembly, budding and release remaining enigmatic are addressed. Cytoplasmic domains of viral surface proteins often serve as a connection to the viral matrix protein or as binding sites for further viral or cellular proteins. A cooperation of MARV GP and VP40 building up the viral envelope can be proposed and is discussed in more detail in this review, as the cytoplasmic domain of GP represents an obvious interaction candidate because of its localization adjacent to the VP40 layer. Interestingly, truncation of the short cytoplasmic domain of GP neither inhibited interaction with VP40 nor incorporation of GP into progeny viral particles. Based on reverse genetics we generated recombinant virions expressing a GP mutant without the cytoplasmic tail. Investigations revealed attenuation in virus growth and an obvious defect in entry. Further investigations showed that the truncation of the cytoplasmic domain of GP impaired the structural integrity of the ectodomain, whichconsequently had impact on entry steps downstream of virus binding. Our data indicated that changes in the cytoplasmic domain are relayed over the lipid membrane to alter the function of the ectodomain.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23186212     DOI: 10.1111/cmi.12076

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  14 in total

Review 1.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

2.  Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

Authors:  Philipp A Ilinykh; Kai Huang; Rodrigo I Santos; Pavlo Gilchuk; Bronwyn M Gunn; Marcus M Karim; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Diptiben V Parekh; James B Kimble; Colette A Pietzsch; Michelle Meyer; Natalia A Kuzmina; Larry Zeitlin; Erica Ollmann Saphire; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

3.  Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances.

Authors:  Gordian Schudt; Larissa Kolesnikova; Olga Dolnik; Beate Sodeik; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

4.  Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.

Authors:  Ziying Han; Jianhong Lu; Yuliang Liu; Benjamin Davis; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Matthias J Schnell; Jay E Wrobel; Allen B Reitz; Ronald N Harty
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

5.  Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression.

Authors:  Shun-Ichiro Oda; Takeshi Noda; Kaveesha J Wijesinghe; Peter Halfmann; Zachary A Bornholdt; Dafna M Abelson; Tammy Armbrust; Robert V Stahelin; Yoshihiro Kawaoka; Erica Ollmann Saphire
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Host Cell Plasma Membrane Phosphatidylserine Regulates the Assembly and Budding of Ebola Virus.

Authors:  Emmanuel Adu-Gyamfi; Kristen A Johnson; Mark E Fraser; Jordan L Scott; Smita P Soni; Keaton R Jones; Michelle A Digman; Enrico Gratton; Charles R Tessier; Robert V Stahelin
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

7.  The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.

Authors:  Jonathan J Madara; Ziying Han; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  Future Virol       Date:  2015-05       Impact factor: 1.831

8.  Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells.

Authors:  Olga Dolnik; Larissa Kolesnikova; Sonja Welsch; Thomas Strecker; Gordian Schudt; Stephan Becker
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

9.  A loop region in the N-terminal domain of Ebola virus VP40 is important in viral assembly, budding, and egress.

Authors:  Emmanuel Adu-Gyamfi; Smita P Soni; Clara S Jee; Michelle A Digman; Enrico Gratton; Robert V Stahelin
Journal:  Viruses       Date:  2014-10-17       Impact factor: 5.048

10.  Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Authors:  Jens H Kuhn; Yīmíng Bào; Sina Bavari; Stephan Becker; Steven Bradfute; Kristina Brauburger; J Rodney Brister; Alexander A Bukreyev; Yíngyún Caì; Kartik Chandran; Robert A Davey; Olga Dolnik; John M Dye; Sven Enterlein; Jean-Paul Gonzalez; Pierre Formenty; Alexander N Freiberg; Lisa E Hensley; Thomas Hoenen; Anna N Honko; Georgy M Ignatyev; Peter B Jahrling; Karl M Johnson; Hans-Dieter Klenk; Gary Kobinger; Matthew G Lackemeyer; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Gustavo Palacios; Jean L Patterson; Janusz T Paweska; Louise Pitt; Sheli R Radoshitzky; Elena I Ryabchikova; Erica Ollmann Saphire; Aleksandr M Shestopalov; Sophie J Smither; Nancy J Sullivan; Robert Swanepoel; Ayato Takada; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Valentina A Volchkova; Victoria Wahl-Jensen; Travis K Warren; Kelly L Warfield; Manfred Weidmann; Stuart T Nichol
Journal:  Arch Virol       Date:  2013-11-05       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.